Phage Therapy for Chronic Bacterial Prostatitis Caused by E. faecalis

Current Understanding of Chronic Bacterial Prostatitis

Chronic bacterial prostatitis (CBP) is an inflammatory condition affecting the prostate gland, with fewer than 10% of prostatitis cases confirmed to have bacterial infection, according to the European Urology guidelines 1, 2
CBP encompasses a broader spectrum of bacterial species than acute bacterial prostatitis, including atypical microorganisms, as reported by the European Urology guidelines 3

Proper phage selection requires comprehensive testing against the patient's specific bacterial isolate, as recommended by The Lancet Microbe guidelines 4, 5
Testing methods include plaque assays to confirm phage activity against the specific E. faecalis strain, as described in The Lancet Microbe guidelines 4
Growth kinetics monitoring is used to assess inhibitory and lytic effects, and evaluation of phage-antibiotic combinations is considered for potential synergistic effects, as reported in The Lancet Microbe guidelines 6
For polymicrobial infections, phage cocktails may be necessary, with testing on mixed bacterial cultures, as recommended by The Lancet Microbe guidelines 6

Phage therapy for CBP is not yet standardized or widely available in most healthcare settings, according to The Lancet Microbe guidelines 4
Treatment requires specialized phage banks and laboratories capable of testing patient isolates against available phages, as reported by The Lancet Microbe guidelines 5
Regulatory frameworks for phage therapy vary by country, often requiring compassionate use authorization, as described in The Lancet Microbe guidelines 4

Confirm diagnosis with the Meares-Stamey 2- or 4-glass test to isolate the causative pathogen, as recommended by the European Urology guidelines 7
If multiple antibiotic treatments fail, consider phage therapy by sending the bacterial isolate to a specialized phage therapy center for testing against available phages, as described in The Lancet Microbe guidelines 4
Select phages with confirmed activity against the specific E. faecalis strain, as recommended by The Lancet Microbe guidelines 6
Consider combination therapy with antibiotics if synergistic effects are demonstrated, as reported in The Lancet Microbe guidelines 6